Lorlatinib for the Treatment of ALK Fusion-Positive Infant-Type Hemispheric Glioma: A Case Report.

导出 LinkOut

翻译打印收藏纠错

作者： Alyssa M,Greenwell ^[1] ; Scott,Baughan ^[2] ; Deniz,Altinok ^[3] ; Neena I,Marupudi ^[4] ; William,Kupsky ^[5] ; Chandan,Kumar-Sinha ^[6] ; Hamza S,Gorsi ^[7]

作者单位： Children's Hospital of Michigan, Detroit, MI. ^[1] Wayne State University School of Medicine, Detroit, MI. ^[2] Department of Radiology, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI. ^[3] Department of Pediatric Neurosurgery, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI. ^[4] Department of Pathology, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI. ^[5] Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI. ^[6] Department of Hematology/Oncology, Children's Hospital of Michigan, Central Michigan University School of Medicine, Mount Pleasant, MI. ^[7]

主题词人类(Humans);内酰胺类, 大环(Lactams, Macrocyclic);吡唑类(Pyrazoles);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);神经胶质瘤(Glioma)

DOI 10.1200/PO.22.00255

PMID 36315913

发布时间 2022-11-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2022年6卷

e2200255页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Lorlatinib for the Treatment of ALK Fusion-Positive Infant-Type Hemispheric Glioma: A Case Report.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lorlatinib for the Treatment of ALK Fusion-Positive Infant-Type Hemispheric Glioma: A Case Report.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除